The global Pneumonia Therapeutics market was valued at US$ 12000 million in 2023 and is anticipated to reach US$ 19010 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

Pneumonia Therapeutics Market

Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection.

The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years.

This report aims to provide a comprehensive presentation of the global market for Pneumonia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia Therapeutics.

Report Scope

The Pneumonia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumonia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumonia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pneumonia Therapeutics Market Report

Report Metric	Details
Report Name	Pneumonia Therapeutics Market
Accounted market size in 2023	US$ 12000 million
Forecasted market size in 2030	US$ 19010 million
CAGR	6.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Vaccines Anti-Infectives Oxygen Therapy
Segment by Application	Hospital Clinic Medical Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pfizer, AstraZeneca, Bayer, Biotest, Tetraphase Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumonia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumonia Therapeutics Market growing?

Ans: The Pneumonia Therapeutics Market witnessing a CAGR of 6.7% during the forecast period 2024-2030.

What is the Pneumonia Therapeutics Market size in 2030?

Ans: The Pneumonia Therapeutics Market size in 2030 will be US$ 19010 million.

Who are the main players in the Pneumonia Therapeutics Market report?

Ans: The main players in the Pneumonia Therapeutics Market are GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pfizer, AstraZeneca, Bayer, Biotest, Tetraphase Pharmaceuticals

What are the Application segmentation covered in the Pneumonia Therapeutics Market report?

Ans: The Applications covered in the Pneumonia Therapeutics Market report are Hospital, Clinic, Medical Center, Other

What are the Type segmentation covered in the Pneumonia Therapeutics Market report?

Ans: The Types covered in the Pneumonia Therapeutics Market report are Vaccines, Anti-Infectives, Oxygen Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pneumonia Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Vaccines

1.2.3 Anti-Infectives

1.2.4 Oxygen Therapy

1.3 Market by Application

1.3.1 Global Pneumonia Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Medical Center

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pneumonia Therapeutics Market Perspective (2019-2030)

2.2 Pneumonia Therapeutics Growth Trends by Region

2.2.1 Global Pneumonia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pneumonia Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Pneumonia Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Pneumonia Therapeutics Market Dynamics

2.3.1 Pneumonia Therapeutics Industry Trends

2.3.2 Pneumonia Therapeutics Market Drivers

2.3.3 Pneumonia Therapeutics Market Challenges

2.3.4 Pneumonia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pneumonia Therapeutics Players by Revenue

3.1.1 Global Top Pneumonia Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Pneumonia Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pneumonia Therapeutics Revenue

3.4 Global Pneumonia Therapeutics Market Concentration Ratio

3.4.1 Global Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Therapeutics Revenue in 2023

3.5 Pneumonia Therapeutics Key Players Head office and Area Served

3.6 Key Players Pneumonia Therapeutics Product Solution and Service

3.7 Date of Enter into Pneumonia Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pneumonia Therapeutics Breakdown Data by Type

4.1 Global Pneumonia Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Pneumonia Therapeutics Forecasted Market Size by Type (2025-2030)

5 Pneumonia Therapeutics Breakdown Data by Application

5.1 Global Pneumonia Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Pneumonia Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pneumonia Therapeutics Market Size (2019-2030)

6.2 North America Pneumonia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pneumonia Therapeutics Market Size by Country (2019-2024)

6.4 North America Pneumonia Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pneumonia Therapeutics Market Size (2019-2030)

7.2 Europe Pneumonia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pneumonia Therapeutics Market Size by Country (2019-2024)

7.4 Europe Pneumonia Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pneumonia Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Pneumonia Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pneumonia Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Pneumonia Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pneumonia Therapeutics Market Size (2019-2030)

9.2 Latin America Pneumonia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pneumonia Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Pneumonia Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pneumonia Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Pneumonia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pneumonia Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Pneumonia Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Pneumonia Therapeutics Introduction

11.1.4 GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Merck Sharp & Dohme

11.2.1 Merck Sharp & Dohme Company Detail

11.2.2 Merck Sharp & Dohme Business Overview

11.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Introduction

11.2.4 Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2019-2024)

11.2.5 Merck Sharp & Dohme Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Pneumonia Therapeutics Introduction

11.3.4 Novartis Revenue in Pneumonia Therapeutics Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Pneumonia Therapeutics Introduction

11.4.4 Pfizer Revenue in Pneumonia Therapeutics Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Detail

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Pneumonia Therapeutics Introduction

11.5.4 AstraZeneca Revenue in Pneumonia Therapeutics Business (2019-2024)

11.5.5 AstraZeneca Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Pneumonia Therapeutics Introduction

11.6.4 Bayer Revenue in Pneumonia Therapeutics Business (2019-2024)

11.6.5 Bayer Recent Development

11.7 Biotest

11.7.1 Biotest Company Detail

11.7.2 Biotest Business Overview

11.7.3 Biotest Pneumonia Therapeutics Introduction

11.7.4 Biotest Revenue in Pneumonia Therapeutics Business (2019-2024)

11.7.5 Biotest Recent Development

11.8 Tetraphase Pharmaceuticals

11.8.1 Tetraphase Pharmaceuticals Company Detail

11.8.2 Tetraphase Pharmaceuticals Business Overview

11.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Introduction

11.8.4 Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2019-2024)

11.8.5 Tetraphase Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Tetraphase Pharmaceuticals

List of Tables

Table 1. Global Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Vaccines

Table 3. Key Players of Anti-Infectives

Table 4. Key Players of Oxygen Therapy

Table 5. Global Pneumonia Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Pneumonia Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pneumonia Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Pneumonia Therapeutics Market Share by Region (2019-2024)

Table 9. Global Pneumonia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Pneumonia Therapeutics Market Share by Region (2025-2030)

Table 11. Pneumonia Therapeutics Market Trends

Table 12. Pneumonia Therapeutics Market Drivers

Table 13. Pneumonia Therapeutics Market Challenges

Table 14. Pneumonia Therapeutics Market Restraints

Table 15. Global Pneumonia Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Pneumonia Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Therapeutics as of 2023)

Table 18. Ranking of Global Top Pneumonia Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Pneumonia Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Pneumonia Therapeutics Product Solution and Service

Table 22. Date of Enter into Pneumonia Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pneumonia Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Pneumonia Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Pneumonia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Pneumonia Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Pneumonia Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Pneumonia Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Pneumonia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Pneumonia Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Pneumonia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Pneumonia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Pneumonia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Pneumonia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Pneumonia Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Pneumonia Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Pneumonia Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Pneumonia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Pneumonia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Pneumonia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Pneumonia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. GlaxoSmithKline Company Detail

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Pneumonia Therapeutics Product

Table 50. GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Merck Sharp & Dohme Company Detail

Table 53. Merck Sharp & Dohme Business Overview

Table 54. Merck Sharp & Dohme Pneumonia Therapeutics Product

Table 55. Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Merck Sharp & Dohme Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Pneumonia Therapeutics Product

Table 60. Novartis Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Pfizer Company Detail

Table 63. Pfizer Business Overview

Table 64. Pfizer Pneumonia Therapeutics Product

Table 65. Pfizer Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Pfizer Recent Development

Table 67. AstraZeneca Company Detail

Table 68. AstraZeneca Business Overview

Table 69. AstraZeneca Pneumonia Therapeutics Product

Table 70. AstraZeneca Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 71. AstraZeneca Recent Development

Table 72. Bayer Company Detail

Table 73. Bayer Business Overview

Table 74. Bayer Pneumonia Therapeutics Product

Table 75. Bayer Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Bayer Recent Development

Table 77. Biotest Company Detail

Table 78. Biotest Business Overview

Table 79. Biotest Pneumonia Therapeutics Product

Table 80. Biotest Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Biotest Recent Development

Table 82. Tetraphase Pharmaceuticals Company Detail

Table 83. Tetraphase Pharmaceuticals Business Overview

Table 84. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product

Table 85. Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Tetraphase Pharmaceuticals Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pneumonia Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pneumonia Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Vaccines Features

Figure 4. Anti-Infectives Features

Figure 5. Oxygen Therapy Features

Figure 6. Global Pneumonia Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Pneumonia Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Medical Center Case Studies

Figure 11. Other Case Studies

Figure 12. Pneumonia Therapeutics Report Years Considered

Figure 13. Global Pneumonia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Pneumonia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Pneumonia Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Pneumonia Therapeutics Market Share by Players in 2023

Figure 17. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Pneumonia Therapeutics Revenue in 2023

Figure 19. North America Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Pneumonia Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Pneumonia Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Pneumonia Therapeutics Market Share by Region (2019-2030)

Figure 33. China Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Pneumonia Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Pneumonia Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Pneumonia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 48. Merck Sharp & Dohme Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 49. Novartis Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 51. AstraZeneca Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 52. Bayer Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 53. Biotest Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 54. Tetraphase Pharmaceuticals Revenue Growth Rate in Pneumonia Therapeutics Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions